These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 18264876
1. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05. Lutsenko H, Doran CM, Hall WD. Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876 [Abstract] [Full Text] [Related]
2. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia. Bertram MY, Lim SS, Wallace AL, Vos T. Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241 [Abstract] [Full Text] [Related]
3. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua. Lutz MA, Lovato P, Cuesta G. Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881 [Abstract] [Full Text] [Related]
4. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales. McEwen A, West R, Owen L. Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600 [Abstract] [Full Text] [Related]
5. Cost-effectiveness of varenicline for smoking cessation. Keiding H. Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093 [Abstract] [Full Text] [Related]
6. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J. Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870 [Abstract] [Full Text] [Related]
7. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC. J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [Abstract] [Full Text] [Related]
8. Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies? Chatkin JM, Mariante de Abreu C, Haggsträm FM, Wagner MB, Fritscher CC. Addiction; 2004 Jun; 99(6):778-84. PubMed ID: 15139876 [Abstract] [Full Text] [Related]
9. Case studies of three pregnant smokers and their use of nicotine replacement therapy. Hotham ED, Gilbert AL, Atkinson ER. Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546 [Abstract] [Full Text] [Related]
10. National trends in the provision of smoking cessation aids within the Veterans Health Administration. Jonk YC, Sherman SE, Fu SS, Hamlett-Berry KW, Geraci MC, Joseph AM. Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855 [Abstract] [Full Text] [Related]
12. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation. Taylor M, Leonardi-Bee J, Agboola S, McNeill A, Coleman T. Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499 [Abstract] [Full Text] [Related]
13. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers. Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T. Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814 [Abstract] [Full Text] [Related]